Gary C K Chan1, Wayne Hall2, Tom P Freeman3, Jason Ferris4, Adrian B Kelly2, Adam Winstock5. 1. Centre for Youth Substance Abuse Research, The University of Queensland, Brisbane, QLD 4029, Australia. Electronic address: c.chan4@uq.edu.au. 2. Centre for Youth Substance Abuse Research, The University of Queensland, Brisbane, QLD 4029, Australia. 3. National Addiction Centre, King's College London, 4 Windsor Walk, London SE5 8BB, UK; Clinical Psychopharmacology Unit, University College London, 1-19 Torrington Place, London WC1E 7HB, UK. 4. Institute for Social Science Research, The University of Queensland, 80 Meiers Road, Brisbane 4068, Australia. 5. Global Drug Survey, Fergusson House,124/128 City Road, London EC1 V2NJ, UK; University College London,Gower Street, London WC1E 6BT, UK.
Abstract
BACKGROUND: Recent reports suggest an increase in use of extremely potent cannabis concentrates such as Butane Hash Oil (BHO) in some developed countries. The aims of this study were to examine the characteristics of BHO users and the effect profiles of BHO. DESIGN: Anonymous online survey in over 20 countries in 2014 and 2015. Participants aged 18 years or older were recruited through onward promotion and online social networks. The overall sample size was 181,870. In this sample, 46% (N=83,867) reported using some form of cannabis in the past year, and 3% reported BHO use (n=5922). MEASUREMENTS: Participants reported their use of 7 types of cannabis in the past 12 months, the source of their cannabis, reasons for use, use of other illegal substances, and lifetime diagnosis for depression, anxiety and psychosis. Participants were asked to rate subjective effects of BHO and high potency herbal cannabis. FINDINGS: Participants who reported a lifetime diagnosis of depression (OR=1.15, p=0.003), anxiety (OR=1.72, p<0.001), and a larger number of substance use (OR=1.29, p<0.001) were more likely to use BHO than only using high potency herbal cannabis. BHO users also reported stronger negative effects and less positive effects when using BHO than high potency herbal cannabis (p<0.001) CONCLUSION: Mental health problems and other illicit drug use were associated with use of BHO. BHO was reported to have stronger negative and weaker positive effects than high potency herbal cannabis.
BACKGROUND: Recent reports suggest an increase in use of extremely potent cannabis concentrates such as Butane Hash Oil (BHO) in some developed countries. The aims of this study were to examine the characteristics of BHO users and the effect profiles of BHO. DESIGN: Anonymous online survey in over 20 countries in 2014 and 2015. Participants aged 18 years or older were recruited through onward promotion and online social networks. The overall sample size was 181,870. In this sample, 46% (N=83,867) reported using some form of cannabis in the past year, and 3% reported BHO use (n=5922). MEASUREMENTS: Participants reported their use of 7 types of cannabis in the past 12 months, the source of their cannabis, reasons for use, use of other illegal substances, and lifetime diagnosis for depression, anxiety and psychosis. Participants were asked to rate subjective effects of BHO and high potency herbal cannabis. FINDINGS:Participants who reported a lifetime diagnosis of depression (OR=1.15, p=0.003), anxiety (OR=1.72, p<0.001), and a larger number of substance use (OR=1.29, p<0.001) were more likely to use BHO than only using high potency herbal cannabis. BHO users also reported stronger negative effects and less positive effects when using BHO than high potency herbal cannabis (p<0.001) CONCLUSION: Mental health problems and other illicit drug use were associated with use of BHO. BHO was reported to have stronger negative and weaker positive effects than high potency herbal cannabis.
Authors: Rachel N Cassidy; Matthew K Meisel; Graham DiGuiseppi; Sara Balestrieri; Nancy P Barnett Journal: Drug Alcohol Depend Date: 2018-05-19 Impact factor: 4.492
Authors: Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall Journal: Nat Rev Dis Primers Date: 2021-02-25 Impact factor: 52.329
Authors: Patricia A Cavazos-Rehg; Melissa J Krauss; Shaina J Sowles; Glennon M Floyd; Elizabeth S Cahn; Veronica L Chaitan; Marisel Ponton Journal: Am J Drug Alcohol Abuse Date: 2018-03-07 Impact factor: 3.829
Authors: Raminta Daniulaityte; Mussa Y Zatreh; Francois R Lamy; Ramzi W Nahhas; Silvia S Martins; Amit Sheth; Robert G Carlson Journal: Drug Alcohol Depend Date: 2018-04-11 Impact factor: 4.492